Difference between revisions of "PET Amyloid Biomarker Ctte"
Jump to navigation
Jump to search
| (24 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
:Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA | :Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA | ||
| − | : | + | :RSNA Staff Support: Julie Lisiecki |
* [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster] | * [http://tinyurl.com/QIBA-PET-Amyloid-Roster Roster] | ||
| Line 20: | Line 20: | ||
==PET Amyloid Meetings/Call Summaries== | ==PET Amyloid Meetings/Call Summaries== | ||
| − | *[[Media: | + | *[[Media:2021_06-11_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|June 11, 2021]] |
| − | *[[Media: | + | *[[Media:2021_05-14_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|May 14, 2021]] |
| − | *[[Media: | + | *[[Media:2021_04-09_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL-AMS.pdf|April 9, 2021]] |
| − | *[[Media: | + | *[[Media:2021_03-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|March 12, 2021]] |
| − | *[[Media: | + | *[[Media:2021_02-12_QIBA_Amyloid_Biomarker_Ctte_Call_Summary_FINAL.pdf|February 12, 2021]] |
| + | |||
| + | |||
'''''[[PET Amyloid BC Call Summaries Archive]]''''' | '''''[[PET Amyloid BC Call Summaries Archive]]''''' | ||
| Line 78: | Line 80: | ||
*[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]] | *[[Media:02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes.pdf|02 13 2015 QIBA PET Amyloid Biomarker Committee Presentation Notes - presented by Dr. Perlman]] | ||
| + | |||
| + | ==QIBA Funded Projects== | ||
| + | |||
| + | ====Round 4==== | ||
| + | *[[Media:Amyloid Profile Continued Support with Brain Phantom Development.pdf | Project (X) Amyloid Profile Continued Support with Brain Phantom Development (University of Iowa)]] | ||
| + | |||
| + | ====Round 5==== | ||
| + | *[[Media:Analyses to Support Amyloid Imaging Profile Development.pdf | Project (A) Analyses to Support Amyloid Imaging Profile Development (ADM Diagnostics, LLC)]] | ||
| + | |||
| + | *[[Media:Amyloid Brain PET Test-Retest Meta-analysis.pdf | Project (E) Amyloid Brain PET Test-Retest Meta-analysis (Johns Hopkins University)]] | ||
| + | |||
| + | *[[Media:A PET-Metabolic Tumor Volume-DRO.pdf | Project (I) A PET-Metabolic Tumor Volume-Digital Reference Object (PET-MTV-DRO) (University of Washington)]] | ||
| + | |||
| + | *[[Media:A Procedure to Facilitate Greater Standardization of PET Spatial Resolution.pdf | Project (J) A Procedure to Facilitate Greater Standardization of PET Spatial Resolution (Johns Hopkins University)]] | ||
Revision as of 16:26, 24 May 2021
- Co-chairs: Satoshi Minoshima, MD, PhD; Anne M. Smith, PhD; Dawn C. Matthews, MS, MBA
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
There is a draft Profile, and current outline of the Claim is:
- SUVr will be the measurand
- The claim will have two components
- 1) Cross-sectional: single subject scan
- 2) Longitudinal: following subject over time
Due to the complexity of having multiple PET Amyloid tracers, a subgroup, the Test-retest Group, has been formed including academics and industry representatives from all of the major PET Amyloid tracer vendors. This group will evaluate the published data on amyloid imaging precision, to determine what level of precision can be claimed in the Profile. The committee’s goal is to have a final draft Profile by December, 2015.
Collaborations: RSNA QIBA is now an affiliate of GAAIN (Global Alzheimer’s Association International Network)
PET Amyloid Meetings/Call Summaries
PET Amyloid BC Call Summaries Archive
PET Amyloid Profile Development
- QIBA PET Amyloid Profile 2017-06-15 (Closed on September 15, 2017)
- QIBA PET Amyloid Profile 2017-04-28 (BC Vote to Release for Public Comment Form: https://goo.gl/forms/0RqF8V6HlXlUNi903)
- QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman} February 10, 2017 (PDF)
- QIBA PET-Amyloid DRAFT Profile - CLEAN {Dr. Perlman} November 11, 2016 (PDF)
- QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman} July 7, 2016 (PDF)
- QIBA PET-Amyloid DRAFT Profile with tracked changes {Dr. Perlman} April 26 - May 5, 2016
Profile Supporting Material
Working Documents
Presentations and Reports
- 06 08 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 05 11 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 04 13 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 03 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 02 09 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Ms. Matthews
- 01 12 2018 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith
- 01 12 2018 QIBA PET Amyloid Profile / ADNI Gap Analysis - presented by Ms. Matthews
- 09 09 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith
- 08 12 2016 QIBA PET Amyloid Biomarker Committee Presentation Slides - presented by Dr. Smith
- 2015-PET-Amyloid DRO Report – Drs. Pierce, Haynor, Sunderland, and Kinahan {Part I} - Discussed on 08 12 2016 WebEx
- 2015-PET-Amyloid DRO Report – Drs. Pierce, Haynor, Sunderland, and Kinahan {Part II} - Discussed on 08 12 2016 WebEx
- Conformance Formulae - Discussed on 08 12 2016 WebEx
- QIBA Conformance Draft - Discussed on 08 12 2016 WebEx